Cellular senescence at the crossroads of inflammation and Alzheimer's disease
- PMID: 34366147
- DOI: 10.1016/j.tins.2021.06.007
Cellular senescence at the crossroads of inflammation and Alzheimer's disease
Abstract
Aging is a key risk factor for Alzheimer's disease (AD), but the reasons for this association are not well understood. Senescent cells accumulate in aged tissues and have been shown to play causal roles in age-related pathologies through their proinflammatory secretome. The question arises whether senescence-induced inflammation might contribute to AD and bridge the gap between aging and AD. Here, we highlight the role of cellular senescence as a driver of the aging phenotype, and discuss the current evidence that connects senescence with AD and neurodegeneration.
Trial registration: ClinicalTrials.gov NCT04785300 NCT04685590.
Keywords: SASP; aging; astrocytes; microglia; neurodegeneration; neuroinflammation.
Copyright © 2021 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of interests A.G. is a named inventor in an MRC patent related to senolytic therapies. B.D.S. is a founder of the company K5 Tx which develops AD drug targets. I.L.A-C. declares no conflicts of interest.
Publication types
MeSH terms
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
